Skip to main content Skip to navigation
Hamburger Menu
Search icon
Location Selector Location Selector
India (English)
Profile Icon Profile Icon
Sign-in/Register UserName
Products

Link Arrow
Solutions

Link Arrow
Discover & Learn

Link Arrow
Resources & Tools

Link Arrow
Support

Link Arrow
Close Menu

Dear Customer,  If you experience any text readability or display issues on our website, please update your web browser to the latest version

See More

Close
Website Feedback
Alert Icon
561431Image1.png

Staining cells with PerCP-Cy™5.5 Annexin V and multicolor flow cytometric analysis of cells undergoing apoptosis. Jurkat T cells were left untreated (Left Panel) or treated for 4 hours (Right Panel) with 6 µM camptothecin. Cells were incubated with PerCP-Cy™5.5 Annexin V (Cat. No. 561431) and analyzed by flow cytometry. Untreated cells were primarily PerCP-Cy™5.5 Annexin V negative, indicating that they were viable and not undergoing apoptosis (Left Panel). After a 4 hour treatment with camptothecin, there were two populations of cells: cells undergoing apoptosis (PerCP-Cy™5.5 Annexin V positive), and cells that were viable and not undergoing apoptosis (PerCP-Cy™5.5 Annexin V negative) (Right Panel). Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.

Annexin_V_PerCp-Cy5-5_treat.png

Staining cells with PerCP-Cy™5.5 Annexin V and multicolor flow cytometric analysis of cells undergoing apoptosis. Jurkat T cells were left untreated (Left Panel) or treated for 4 hours (Right Panel) with 6 µM camptothecin. Cells were incubated with PerCP-Cy™5.5 Annexin V (Cat. No. 561431) and analyzed by flow cytometry. Untreated cells were primarily PerCP-Cy™5.5 Annexin V negative, indicating that they were viable and not undergoing apoptosis (Left Panel). After a 4 hour treatment with camptothecin, there were two populations of cells: cells undergoing apoptosis (PerCP-Cy™5.5 Annexin V positive), and cells that were viable and not undergoing apoptosis (PerCP-Cy™5.5 Annexin V negative) (Right Panel). Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.

561431Image1.png Annexin_V_PerCp-Cy5-5_treat.png Amber-Cap-Blue-Label.jpg

Staining cells with PerCP-Cy™5.5 Annexin V and multicolor flow cytometric analysis of cells undergoing apoptosis. Jurkat T cells were left untreated (Left Panel) or treated for 4 hours (Right Panel) with 6 µM camptothecin. Cells were incubated with PerCP-Cy™5.5 Annexin V (Cat. No. 561431) and analyzed by flow cytometry. Untreated cells were primarily PerCP-Cy™5.5 Annexin V negative, indicating that they were viable and not undergoing apoptosis (Left Panel). After a 4 hour treatment with camptothecin, there were two populations of cells: cells undergoing apoptosis (PerCP-Cy™5.5 Annexin V positive), and cells that were viable and not undergoing apoptosis (PerCP-Cy™5.5 Annexin V negative) (Right Panel). Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.

Staining cells with PerCP-Cy™5.5 Annexin V and multicolor flow cytometric analysis of cells undergoing apoptosis. Jurkat T cells were left untreated (Left Panel) or treated for 4 hours (Right Panel) with 6 µM camptothecin. Cells were incubated with PerCP-Cy™5.5 Annexin V (Cat. No. 561431) and analyzed by flow cytometry. Untreated cells were primarily PerCP-Cy™5.5 Annexin V negative, indicating that they were viable and not undergoing apoptosis (Left Panel). After a 4 hour treatment with camptothecin, there were two populations of cells: cells undergoing apoptosis (PerCP-Cy™5.5 Annexin V positive), and cells that were viable and not undergoing apoptosis (PerCP-Cy™5.5 Annexin V negative) (Right Panel). Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.

Product Details
Down Arrow Up Arrow


BD Pharmingen™
Human (QC Testing)
Flow cytometry (Routinely Tested)
5 µl
AB_10714630
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
RUO


Preparation And Storage

The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with PerCP-Cy5.5 under optimum conditions, and unconjugated antibody and free PerCP-Cy5.5 were removed. Storage of PerCP-Cy5.5 conjugates in unoptimized diluent is not recommended and may result in loss of signal intensity. Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Show More blue down arrow Show Less blue up arrow

Recommended Assay Procedures

PerCP-Cy™5.5 Annexin V is a sensitive probe for identifying apoptotic cells, binding to negatively charged phospholipid surfaces with a higher affinity for phosphatidylserine (PS) than most other phospholipids. PerCP-Cy™5.5 Annexin V binding is calcium dependent and defined calcium and salt concentrations are required for optimal staining as described in the PerCP-Cy™5.5 Annexin V Staining Protocol. Investigators should note that PerCP-Cy™5.5 Annexin V flow cytometric analysis on adherent cell types (eg, HeLa, NIH 3T3, etc.) is not routinely tested as specific membrane damage may occur during cell detachment or harvesting. Methods for utilizing Annexin V for flow cytometry on adherent cell types, however, have been previously reported (Casiola-Rosen et al. and van Engelend et al.).

INDUCTION OF APOPTOSIS BY CAMPTOTHECIN

The following protocol is provided as an illustration on how PerCP-Cy™5.5 Annexin V may be used on a cell line (Jurkat).

Materials

1. Prepare Camptothecin stock solution (Sigma-Aldrich Cat. No. C-9911): 1 mM in DMSO.

2. Jurkat T cells (ATCC TIB-152).

Procedure

1. Add Camptothecin (final conc. 4-6 µM) to 1 × 10^6 Jurkat cells.

2. Incubate the cells for 4-6 hr at 37°C.

3. Proceed with the PerCP-Cy™5.5 Annexin V Staining Protocol to measure apoptosis.

PerCP-Cy™5.5 ANNEXIN V STAINING PROTOCOL

Reagents

1. PerCP-Cy™5.5 Annexin V: Included. Use 5 µl per test.

2. 10X Annexin Binding Buffer: Not Included. 0.1 M Hepes (pH 7.4) 1.4 M NaCl, 25 mM CaCl2. Store at 4°C. Alternatively, BD Pharmingen™ Annexin V Binding Buffer, 10X concentrate (Cat. No. 556454) may be purchased.

Staining

1. Wash cells twice with cold PBS and then resuspend cells in 1× Binding Buffer at a concentration of 1 × 10^6 cells/ml.

2. Transfer 100 µl of the solution (1 × 10^5 cells) to a 5 ml culture tube.

3. Add 5 µl of PerCP-Cy™5.5 Annexin V.

4. Gently vortex the cells and incubate for 15 min at RT (25°C) in the dark.

5. Add 400 µl of 1× Binding Buffer to each tube. Analyze by flow cytometry within 1 hr.

SUGGESTED CONTROLS FOR SETTING UP FLOW CYTOMETRY

The following controls are used to set up markers for quantifying PerCP-Cy™5.5 Annexin V-positive cells:

1. Unstained cells.

2. Cells stained with PerCP-Cy™5.5 Annexin V alone.

Other Staining Controls

A cell line that can be easily induced to undergo apoptosis should be used to obtain positive control staining with PerCP-Cy™5.5 Annexin V. It is important to note that the basal level of apoptosis and necrosis varies considerably within a population. Thus, even in the absence of induced apoptosis, most cell populations will contain a minor percentage of cells that are positive for apoptosis (PerCP-Cy™5.5 Annexin V positive cell).

The untreated population is used to define the basal level of apoptotic and dead cells. The percentage of cells that have been induced to undergo apoptosis is then determined by subtracting the percentage of apoptotic cells in the untreated population from the percentage of apoptotic cells in the treated population.

Show More blue down arrow Show Less blue up arrow

Product Notices

  1. Please observe the following precautions: Absorption of visible light can significantly alter the energy transfer occurring in any tandem fluorochrome conjugate; therefore, we recommend that special precautions be taken (such as wrapping vials, tubes, or racks in aluminum foil) to prevent exposure of conjugated reagents, including cells stained with those reagents, to room illumination.
  2. PerCP-Cy5.5 is optimized for use with a single argon ion laser emitting 488-nm light. Because of the broad absorption spectrum of the tandem fluorochrome, extra care must be taken when using dual-laser cytometers, which may directly excite both PerCP and Cy5.5™. We recommend the use of cross-beam compensation during data acquisition or software compensation during data analysis.
  3. PerCP-Cy5.5–labelled antibodies can be used with FITC- and R-PE–labelled reagents in single-laser flow cytometers with no significant spectral overlap of PerCP-Cy5.5, FITC, and R-PE fluorescence.
  4. This product is subject to proprietary rights of Amersham Biosciences Corp. and Carnegie Mellon University and made and sold under license from Amersham Biosciences Corp. This product is licensed for sale only for research. It is not licensed for any other use. If you require a commercial license to use this product and do not have one return this material, unopened to BD Biosciences, 10975 Torreyana Rd, San Diego, CA 92121 and any money paid for the material will be refunded.
  5. Cy is a trademark of Amersham Biosciences Limited. This conjugated product is sold under license to the following patents: US Patent Nos. 5,486,616; 5,569,587; 5,569,766; 5,627,027.
  6. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
  7. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
  8. For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
  9. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
Show More blue down arrow Show Less blue up arrow
561431 Rev. 1
Antibody Details
Down Arrow Up Arrow
Annexin V

Apoptosis is a normal physiologic process which occurs during embryonic development as well as in maintenence of tissue homeostasis. The apoptotic program is characterized by certain morphologic features, including loss of plasma membrane asymmetry and attachment, condensation of the cytoplasm and nucleus, and internucleosomal cleavage of DNA. Loss of plasma membrane is one of the earliest features. In apoptotic cells, the membrane phospholipid phosphatidylserine (PS) is translocated from the inner to the outer leaflet of the plasma membrane, thereby exposing PS to the external cellular environment. Annexin V is a 35-36 kDa Ca2+ dependent phospholipid-binding protein that has a high affinity for PS, and binds to cells with exposed PS. Annexin V may be conjugated to fluorochromes including PerCP-Cy™5.5 Annexin V. This format retains its high affinity for PS and thus serves as a sensitive probe for flow cytometric analysis of cells that are undergoing apoptosis. Since externalization of PS occurs in the earlier stages of apoptosis, PerCP-Cy™5.5 Annexin V staining can identify apoptosis at an earlier stage than assays based on nuclear changes such as DNA fragmentation.

NOTE:  Investigators should note that the use of Propidium Iodide (PI) or 7-Amino-Actinomycin D (7-AAD) for co-staining with PerCP-Cy5.5 Annexin V  is not recommended due to spectral overlap.

561431 Rev. 1
Format Details
Down Arrow Up Arrow
PerCP-Cy5.5
PerCP-Cy5.5 dye is part of the BD blue family of dyes. This tandem fluorochrome is comprised of a fluorescent protein complex (PerCP) with an excitation maximum (Ex Max) of 482 nm and an acceptor dye with an emission maximum (Em Max) at 676 nm. PerCP-Cy5 is designed to be excited by the blue laser (488-nm) and detected using an optical filter centered near 680 nm (e.g., a 695/40 nm bandpass filter). The donor dye can be partially excited by the Violet (405-nm) laser resulting in cross-laser excitation and fluorescence spillover. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.
altImg
PerCP-Cy5.5
482 nm
676 nm
561431 Rev.1
Citations & References
Down Arrow Up Arrow
View product citations for antibody "561431" on CiteAb

Development References (8)

  1. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem. 1990; 265(9):4923-4928. (Biology). View Reference
  2. Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1996; 93(4):1624-1629. (Methodology: Apoptosis, Flow cytometry). View Reference
  3. Homburg CH, de Haas M, von dem Borne AE, Verhoeven AJ, Reutelingsperger CP, Roos D. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood. 1995; 85(2):532-540. (Biology). View Reference
  4. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994; 84(5):1415-1420. (Methodology: Apoptosis, Flow cytometry). View Reference
  5. Martin SJ, Reutelingsperger CP, McGahon AJ, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995; 182(5):1545-1556. (Biology). View Reference
  6. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta. 1994; 1197(1):63-93. (Biology). View Reference
  7. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995; 184(1):39-51. (Methodology: Apoptosis, Flow cytometry). View Reference
  8. van Engeland M, Ramaekers FC, Schutte B, Reutelingsperger CP. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry. 1996; 24(2):131-139. (Methodology: Apoptosis, Flow cytometry). View Reference
View All (8) View Less
561431 Rev. 1

Please refer to Support Documents for Quality Certificates

 

Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described

 

Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.